Suppr超能文献

用于MRI引导的抗炎和抗肿瘤治疗的可切换ROS清除剂/生成器,具有增强的治疗效果和减少的副作用。

Switchable ROS Scavenger/Generator for MRI-Guided Anti-Inflammation and Anti-Tumor Therapy with Enhanced Therapeutic Efficacy and Reduced Side Effects.

作者信息

Li Muyao, Huo Linlin, Zeng Jie, Zhu Guifen, Liu Xiangqing, Zhu Xianglong, Huang Guoming, Wang Yi, Ni Kaiyuan, Zhao Zhenghuan

机构信息

College of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, P. R. China.

College of Biological Science and Engineering, Fuzhou University, Fuzhou, 350116, P. R. China.

出版信息

Adv Healthc Mater. 2023 Feb;12(5):e2202043. doi: 10.1002/adhm.202202043. Epub 2022 Nov 24.

Abstract

Photosensitizer in photodynamic therapy (PDT)  accumulates in both tumor and adjacent normal tissue due to low selective biodistribution, results in undesirable side effect with limited clinic application. Herein, an intelligent nanoplatform is reported that selectively acts as reactive oxygen species (ROS) scavenger in normal tissue but as ROS generator in tumor microenvironment (TME) to differentially control ROS level in tumor and surrounding normal tissue during PDT. By down-regulating the produced ROS with dampened cytokine wave in normal tissue after PDT, the nanoplatform reduces the inflammatory response of normal tissue in PDT, minimizing the side effect and tumor metastasis in PDT. Alternatively, the nanoplatform switches from ROS scavenger to generator through the glutathione (GSH) responsive degradation in TME, which effectively improves the PDT efficacy with reduced GSH level and amplified oxidative stress in tumor. Simultaneously, the released Mn ions provide real-time and in situ signal change of magnetic resonance imaging (MRI) to monitor the reversal process of catalysis activity and achieve accurate tumor diagnosis. This TME-responsive ROS scavenger/generator with activable MRI contrast may provide a new dimension for design of next-generation PDT agents with precise diagnosis, high therapeutic efficacy, and low side effect.

摘要

光动力疗法(PDT)中的光敏剂由于生物分布选择性低,会在肿瘤组织和邻近正常组织中均有积累,导致不良副作用,限制了其临床应用。在此,报道了一种智能纳米平台,其在正常组织中选择性地作为活性氧(ROS)清除剂,但在肿瘤微环境(TME)中作为ROS生成剂,在PDT过程中差异控制肿瘤组织和周围正常组织中的ROS水平。通过在PDT后下调正常组织中产生的ROS并减弱细胞因子波动,该纳米平台降低了PDT中正常组织的炎症反应,使PDT中的副作用和肿瘤转移最小化。另外,该纳米平台通过TME中的谷胱甘肽(GSH)响应性降解从ROS清除剂转变为生成剂,随着肿瘤中GSH水平降低和氧化应激增强,有效提高了PDT疗效。同时,释放的锰离子提供磁共振成像(MRI)的实时原位信号变化,以监测催化活性的逆转过程并实现准确的肿瘤诊断。这种具有可激活MRI造影的TME响应性ROS清除剂/生成剂可为设计具有精确诊断、高治疗效果和低副作用的下一代PDT药物提供新的思路。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验